U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics’ mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I Disorder
On Apr. 28, 2026, Laguna Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough…